Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy

Case Reports

Amy K Ricke et al. Biol Psychiatry. 2011.

. 2011 Aug 15;70(4):e13-4.

doi: 10.1016/j.biopsych.2011.02.030. Epub 2011 May 6.

No abstract available

Conflict of interest statement

The authors report no biomedical financial interests or potential conflicts of interest.

Reply to: Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
Altinay M, Anand A. Altinay M, et al. Biol Psychiatry. 2013 Nov 15;74(10):e25. doi: 10.1016/j.biopsych.2013.03.019. Epub 2013 May 28. Biol Psychiatry. 2013. PMID: 23726510 No abstract available.
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
Niciu MJ, Luckenbaugh DA, Ionescu DF, Mathews DC, Richards EM, Zarate CA Jr. Niciu MJ, et al. Biol Psychiatry. 2013 Nov 15;74(10):e23-4. doi: 10.1016/j.biopsych.2013.01.038. Epub 2013 May 28. Biol Psychiatry. 2013. PMID: 23726512 Free PMC article. No abstract available.

1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–354. - PubMed
1. Zarate CA, Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856–864. - PubMed
1. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry. 2000;57:270–276. - PubMed
1. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010;67:793–802. - PMC - PubMed
1. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199–214. - PubMed